A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study to Evaluate The Efficacy, Safety, and Tolerability of A Clostridium Difficile Vaccine In Adults 50 Years Of Age and Older
We are conducting a study to find out if an investigational vaccine prevents severe diarrhea caused by a germ (bacterium) called Clostridium difficile (C diff) in subjects 50 year of age and older.
|Clinical Study Identifier||TX11887|
|Last Modified on||7 November 2020|
Select a piece of text and start making personal notes.
Congrats! You have your own personal workspace now.